UK Health Minister Abandons Plan for Smoke-Free 2030

Dec.13.2022
UK Health Minister Abandons Plan for Smoke-Free 2030
UK Health Minister cancels plan to make country smoke-free by 2030, keeping legal tobacco buying age at 18.

Health Minister Steve Barclay has announced the cancellation of a plan to make the country smoke-free by 2030, ending hopes of saving an additional 500,000 lives.


Sources from the White House have reported that they are abandoning plans to raise the legal age for tobacco purchases by one year each year until no one can purchase cigarettes.


This means that the minimum legal age for tobacco sales will remain at 18 years old. Anti-smoking activists argue that this is a missed opportunity to reduce smoking rates among young people by one-third.


Smoking is unlikely to be abandoned as a public health issue by any responsible government aiming for a smoke-free future by 2030, according to Deborah Arnott of the Action on Smoking and Health organization.


This is a government in the final stages that clearly lacks imagination and has lost its courage.


Former Minister of Health, Saeed Javed's goal was to lower the proportion of smokers in the population from over 13% to 5% within seven years, effectively defining a smoke-free target.


He commissioned Dr. Javed Khan, former head of the Barnardo's charity, to publish a report in June to fulfill the Conservative Party's 2019 manifesto promise of extending life expectancy by five years by 2035.


Dr. Khan stated that the government will only achieve its smoke-free goal within seven years if his measures are implemented.


He also hopes to see ministers invest £125 million to help people quit smoking, prescribe e-cigarettes, and ban outdoor smoking in areas where children gather.


Mr. Khan added, "We need to make smoking as difficult as possible and make quitting as easy as possible.


These intervention measures are crucial. There are no shortcuts, no quick fixes, and no excuses.


David Buck, from the King's Fund health think tank, commented on changes in age demographics, stating: "This is a very intelligent proposal. It can assist individuals, manufacturers, and retailers in planning for long-term changes.


Ms. Arnott supports raising the age limit to 21 years old. She claims that this measure would decrease smoking rates in the age group of 18-21 by 30%.


Smoking leads to 75,000 deaths each year in England and costs the NHS £2.4 billion.


Bob Blackman, the chairman of the All-Party Parliamentary Group on Smoking and Health and a Conservative MP, has stated that downplaying the UK's tobacco strategy could have adverse effects on reducing NHS waiting lists.


The number of deaths caused by tobacco is 30 times higher than the number of deaths caused by smoking-related illnesses.


Even though the Health Secretary Neil O'Brien told Members of Parliament 12 days ago that "we are considering the potential benefits of raising the age at which tobacco products can be sold, but age increase has been cancelled.


A spokesperson for the Department of Health and Social Care (DHSC) stated, "We are currently considering the extensive suggestions put forth in Khan's remarks.


2FIRSTS will continue to cover this topic and provide ongoing updates on the "2FIRSTS APP." Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Major U.S.  Vape Distributor Demand Vape Pays at Least $300,000 for White House Lobbying Amid Enforcement Pressure
Major U.S. Vape Distributor Demand Vape Pays at Least $300,000 for White House Lobbying Amid Enforcement Pressure
New York vape distributor Ecto World, which operates as Demand Vape, hired political consultant Roger Stone to lobby the Executive Office of the President on regulation of vaping and related products while facing state enforcement and multiple lawsuits. Public lobbying disclosures show that Ecto World paid at least $300,000 for the work through June 30, 2026. Separately, New York State announced in March that more than 28,500 pounds of vaping products tied to the company had been seized, while New York City and the state have pursued legal or enforcement actions. Public records do not show that the lobbying directly changed any specific regulatory or enforcement outcome.
Sep.08
Imperial Brands Plans Thousands of Job Cuts Across U.S. and Europe in Cost Restructuring
Imperial Brands Plans Thousands of Job Cuts Across U.S. and Europe in Cost Restructuring
According to Reuters, citing Bloomberg News, British tobacco company Imperial Brands PLC plans to cut thousands of jobs across the United States and Europe as part of a cost reduction and organizational restructuring effort. The announcement drew market attention to the company’s shares. The move comes as global tobacco companies continue adjusting their operations amid slower cigarette market growth, changing consumer preferences and the transition toward next-generation nicotine products.
Aug.11
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
A new expert paper in JAMA urges U.S. clinicians to include nicotine e-cigarettes in smoking-cessation discussions, citing higher quit rates than nicotine replacement therapy. It also stresses that products must deliver enough nicotine to replace cigarettes, dual use should be brief, and complete switching is the goal. 2Firsts argues the recommendations matter beyond clinics: public-health professionals should reassess relative risk, regulators should preserve sufficient product appeal for adult smokers, and manufacturers should focus on helping users quit cigarettes more sustainably.
SCIENCE
Aug.03 by 2Firsts Perspectives
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11